Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ShellfishGene
    Member
    • Mar 2009
    • 14

    #1

    Quality checking transcriptome assemblies

    Dear all,

    I am currently working on 454 transcriptome data. I have assembled the reads using the current newbler version, MIRA, and will try Velvet/Oases later on.
    However, I am still not sure how to decide on one assembly to use for all further analysis. Comparing the basic statistics like contig length, reads per contig, N50 and so on only gives hints to which may be the better assembly. From these stats I would have choosen the newbler assembly, but they do not really tell me how well the transcripts are assembled. Alternative splicing and gene copies can make for bad assemblies, for example.
    Some methods I thought of that may tell me more are looking at single genes that have a known sequence, and check how the transcripts for these genes are assembled. However, that has to be done manually, and is only possible for a few genes.
    Maybe one could also blast all contigs and check which assembly gives more or better hits, or how many hits one contig has on average. Too many hits per contig could maybe mean that multiple transcripts are assembled to one contig.

    How do you check assembly quality beyond the basic stats? Without a sequenced genome, of course.

    Cheers,

    Till
  • Xi Wang
    Senior Member
    • Oct 2009
    • 317

    #2
    It is mentioned by Oases that the transcriptome assembly is quite different from genome assembly, due to the alternative splicing and different gene expression levels. Therefore, the old statistics may not be applicable to transcriptome assembly.
    Xi Wang

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...